cephalexin has been researched along with Communicable Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Braswell, M; Brodell, RT; Davis, A; Jackson, JD; Zieman, D | 1 |
| Cohen, PR | 1 |
| Helwig, H; Hueppchen, C; Kunz, H | 1 |
3 other study(ies) available for cephalexin and Communicable Diseases
| Article | Year |
|---|---|
Erythematous ear with drainage.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cephalexin; Child; Communicable Diseases; Ear Diseases; Eczema; Erythema; Humans; Male; Prednisone; Treatment Outcome | 2021 |
Community-acquired methicillin-resistant Staphylococcus aureus skin infection presenting as a periumbilical folliculitis.
Topics: Abdomen; Adult; Anti-Bacterial Agents; Cephalexin; Communicable Diseases; Diagnosis, Differential; Drug Therapy, Combination; Female; Folliculitis; Glucocorticoids; Humans; Male; Methicillin Resistance; Staphylococcal Skin Infections; Staphylococcus aureus; Triamcinolone Acetonide | 2006 |
Effectiveness and tolerance of cephalexin in children.
Topics: Administration, Oral; Adolescent; Cephalexin; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Drug Tolerance; Humans; Infant; Infant, Newborn; Lung Diseases; Pyelonephritis | 1972 |